This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Arrayit Corporation Participates In The International Plant And Animal Genome Conference XXII; Hosts Technology Workshop “Breakthroughs In Microarray Technology”

Arrayit Corporation (OTCQB:ARYC), a life sciences and molecular diagnostics leader, announces that the Company has showcased its leading-edge microarray technology at the 22 nd Annual International Plant and Animal Genome Conference (PAG XXII) in San Diego, California, held on January 11-15, 2014. PAG XXII, the largest agricultural genomics meeting in the world, features more than 3,200 scientists, 130 exhibits, 150 workshops, 1,000 posters and 1,800 abstracts. Plant and animal genomics focuses on research and product development based on the DNA sequence genetic blueprints of crop plants, botanical species, livestock, and bacterial and viral pathogens that can compromise food quality and safety.

Arrayit presented the Company’s leading-edge, patented and proprietary microarray products and services and hosted a technology workshop entitled “Breakthroughs in Microarray Technology” that included luminary speakers, guest scientist appearances and attendee raffles.

Mark Schena, President of Arrayit Corporation, commented, “The PAG XXII conference was very successful for us, resulting in a record number of sales leads and providing an effective forum to present our innovative technology and solutions to the industry. We are thrilled about the positive reception and look forward to building on the many relationships we developed.”

About Arrayit Corporation

Arrayit utilizes its patented and proprietary microarray platform to lead and empower the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.

- Powerful Science for Life™

Visit for more information.

Safe Harbor Statement

We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2012 and in Form 10-Q for the quarterly period ended September 30, 2013.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,719.92 -78.57 -0.44%
S&P 500 2,080.41 -9.70 -0.46%
NASDAQ 5,108.6660 -18.8590 -0.37%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs